Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Mol Cancer Ther. 2016 May 27;15(8):1809–1822. doi: 10.1158/1535-7163.MCT-15-0688

Table 1.

The analysis of drug interaction in cell growth assay as in Fig. 2F using multiple statistical methods described in Supplementary Methods.

Models Drug interaction Parameter Estimated 95% Cl Conclusion
Syn. Add. Ant.
II < 1 II = 1 II > 1
Chou and Talalay Eribulin=1, MLN =50 0.688 (0.573, 0.825) Synergy
Eribulin=3, MLN =100 0.468 (0.334, 0.654) Synergy
Eribulin=5, MLN =100 0.669 (0.519, 0.866) Synergy
Eribulin=3, MLN =150 0.427 (0.269, 0.677) Synergy
Eribulin=5, MLN =150 0.505 (0.345, 0.738) Synergy
Greco α>0 α=0 α<0 0.949 (0.187, 1.711) Synergy
Machado 0<h<1 h=0 h>1 0.613 (0.474, 0.753) Synergy